Stephanie Federico

About Stephanie Federico

Stephanie Federico, With an exceptional h-index of 20 and a recent h-index of 13 (since 2020), a distinguished researcher at Università degli Studi di Trieste, specializes in the field of Medicinal chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta

Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme

Gaucher Disease: A Glance from a Medicinal Chemistry Perspective

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors

[1,2,4]Triazolo[1,5‐c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines

Adenosine Receptor Ligands, Probes, and Functional Conjugates: A 20-Year History of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidines (PTP)

Front Cover: Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors (ChemMedChem 14/2023)

Are two riboses better than one? The case of the recognition and activation of adenosine receptors

Stephanie Federico Information

University

Position

Department of Chemical and Pharmaceutical Sciences

Citations(all)

991

Citations(since 2020)

545

Cited By

664

hIndex(all)

20

hIndex(since 2020)

13

i10Index(all)

36

i10Index(since 2020)

21

Email

University Profile Page

Google Scholar

Stephanie Federico Skills & Research Interests

Medicinal chemistry

Top articles of Stephanie Federico

Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta

Pharmaceuticals

2024/4/7

Stephanie Federico
Stephanie Federico

H-Index: 12

Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme

Medicinal Chemistry Research

2024/2/28

Stephanie Federico
Stephanie Federico

H-Index: 12

Gaucher Disease: A Glance from a Medicinal Chemistry Perspective

2024/2/8

Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors

Biomolecules

2023/11/3

Tatiana Da Ros
Tatiana Da Ros

H-Index: 28

Stephanie Federico
Stephanie Federico

H-Index: 12

[1,2,4]Triazolo[1,5‐c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines

ChemMedChem

2023/11/2

Stephanie Federico
Stephanie Federico

H-Index: 12

Tatiana Da Ros
Tatiana Da Ros

H-Index: 28

Adenosine Receptor Ligands, Probes, and Functional Conjugates: A 20-Year History of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidines (PTP)

2023/8/19

Tatiana Da Ros
Tatiana Da Ros

H-Index: 28

Stephanie Federico
Stephanie Federico

H-Index: 12

Front Cover: Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors (ChemMedChem 14/2023)

ChemMedChem

2023/7/17

Are two riboses better than one? The case of the recognition and activation of adenosine receptors

ChemMedChem

2023/7/17

“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies

Pharmaceuticals

2023/1/23

Chang Cui
Chang Cui

H-Index: 8

Matteo Pavan
Matteo Pavan

H-Index: 1

Stephanie Federico
Stephanie Federico

H-Index: 12

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis

ACS Chemical Neuroscience

2022/7/22

The multifaceted role of GPCRs in amyotrophic lateral sclerosis: a new therapeutic perspective?

2022/4/19

Matteo Pavan
Matteo Pavan

H-Index: 1

Stephanie Federico
Stephanie Federico

H-Index: 12

Promising Targets and Strategies to Control Neuroinflammation (Part II)

Current Medicinal Chemistry

2022/8/1

Stephanie Federico
Stephanie Federico

H-Index: 12

Glycogen synthase kinase 3β involvement in neuroinflammation and neurodegenerative diseases

2022/8/1

Stephanie Federico
Stephanie Federico

H-Index: 12

A computational workflow for the identification of novel fragments acting as inhibitors of the activity of protein kinase CK1δ

International Journal of Molecular Sciences

2021/9/9

Matteo Pavan
Matteo Pavan

H-Index: 1

Stephanie Federico
Stephanie Federico

H-Index: 12

Developing novel classes of protein kinase CK1δ inhibitors by fusing [1, 2, 4] triazole with different bicyclic heteroaromatic systems

European Journal of Medicinal Chemistry

2021/4/15

Potent and selective A 3 adenosine receptor antagonists bearing aminoesters as heterobifunctional moieties

RSC Medicinal Chemistry

2021

Stephanie Federico
Stephanie Federico

H-Index: 12

Targeting G Protein‐Coupled Receptors with Magnetic Carbon Nanotubes: The Case of the A3 Adenosine Receptor

ChemMedChem

2020/10/19

Scaffold Repurposing of in-House Chemical Library toward the Identification of New Casein Kinase 1 δ Inhibitors

ACS Medicinal Chemistry Letters

2020/4/28

Stephanie Federico
Stephanie Federico

H-Index: 12

Alice Valentini
Alice Valentini

H-Index: 2

Conjugable A3 adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes

European journal of medicinal chemistry

2020/1/15

Stephanie Federico
Stephanie Federico

H-Index: 12

See List of Professors in Stephanie Federico University(Università degli Studi di Trieste)